RETOGATEIN
UNII ME3BUS4RYT

Substance Identification & Data

This profile provides standardized clinical and technical data for Retogatein, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ME3BUS4RYT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2938906-46-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ME3BUS4RYT
CAS Registry Number
2938906-46-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RETOGATEIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13133
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Retogatein. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

2-585-GLUTAMATE DECARBOXYLASE 2 (HUMAN CLONE RHGAD65)
N2.1-ACETYL-(DES-N-TERMINAL METHIONYL)-GLUTAMATE DECARBOXYLASE 2 (HOMO SAPIENS) (GAD2, 65 KDA GLUTAMIC ACID DECARBOXYLASE, GLUTAMATE DECARBOXYLASE 65 KDA ISOFORM, GAD65, EC:4.1.1.15), PRODUCED IN SPODOPTERA FRUGIPERDA INSECT CELLS (CELL LINE SF9)
RETOGATEIN
RETOGATEIN [INN]